| Mepha Pharma AG - Ginkgo-Mepha 120 mg, Filmtabletten | | 63202 | | 02 | | Ginkgo-Mepha 120 mg | | Filmtabletten | | N06DX02 | | Ginkgo biloba | | 23.12.2015 | | |
| | Composition | | ginkgonis extractum siccum raffinatum et quantificatum (Ginkgo biloba L., folium) 120 mg corresp. flavonglycosida ginkgo 26.4-32.4 mg et bilobalidum 3.12-3.84 mg et ginkgolidae A, B et C 3.36-4.08 mg, DER: 35-67:1, Auszugsmittel acetonum 60% (m/m), glucosum liquidum dispersione desiccatum 6.316 mg, lactosum monohydricum 380.294 mg, cellulosum microcristallinum, carmellosum natricum conexum corresp. natrium 1.32 mg, silica colloidalis anhydrica, magnesii stearas, Überzug: poly(alcohol vinylicus), macrogolum 3350, E 171, talcum, E 172 (flavum), pro compresso obducto. | | Packungsbestandteile | | Comprimés filmés | | | | | Principe actif | Concentr. |
|---|
| Ginkgonis Extractum Siccum Raffinatum et Quantificatum (Ginkgo Biloba l., Folium) | 120 mg correspond Flavonglycosida Ginkgo 26.4-32.4 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Ginkgonis Extractum Siccum Raffinatum et Quantificatum | 120 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| (Flavum) | | | | Auszugsmittel Acetonum 60% (M/m) | | | | B | | | | Bilobalidum | 3.12-3.84 mg | | | C | 3.36-4.08 mg | | | Carmellosum Natricum Conexum | | | | Cellulosum Microcristallinum | | | | Der: 35-67:1 | | | | E 171 | | color. | | E 172 | | color. | | Ginkgolidae A | | | | Glucosum Liquidum Dispersione Desiccatum | 6.316 mg | | | Lactose Monohydrate | 380.294 mg | | | Macrogol | 3350 | | | Magnesii Stearas | | | | Poly(Alcohol Vinylicus) | | Überzug | | Pro Compresso Obducto | | | | Silica Colloidalis Anhydrica | | | | Talcum | | |
| |
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 003 | 60 Comprimé(s) | 28.70 | 47.65 | B | LS | Oui | | 004 | 120 Comprimé(s) | 50.51 | 71.35 | B | LS | Oui |
|
|
